Oncology Nursing Society (ONS)
Cancer Chemotherapy and Biotherapy
Course
Course Overview
The Oncology Nursing Society’s (O...
• Discuss safety precautions necessary when handling cytotoxic
agents.
• Review chemotherapy dose calculations and practic...
Safe practice considerations
Administration
Dose determination
Pre-treatment care
Routes of administration
Immediate compl...
Fatigue
Alterations in Sexual and Reproductive function
Secondary Malignancies
Survivorship Care Plan
Case Studies
Target ...
Stephanie Grospe, MSN, RN, OCN
Melanie Harrow, BSN, RN, OCN
Kathy Leifeste, RN, MSN, AOCN
Leah Scaramuzzo, MSN, RNC, AOCN
...
Upcoming SlideShare
Loading in...5
×

Oncology Nursing Society (ONS)

587

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
587
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Oncology Nursing Society (ONS)

  1. 1. Oncology Nursing Society (ONS) Cancer Chemotherapy and Biotherapy Course Course Overview The Oncology Nursing Society’s (ONS) Chemotherapy and Biotherapy Course provides a comprehensive review of the knowledge needed to administer cytotoxic and biotherapeutic agents. The ONS Chemotherapy and Biotherapy Course is NOT a certification course, and is not intended to measure competency. Individual institutions are responsible for determining their own requirements for assessing clinical competency. Upon successful completion of the course and post-test, participants will receive an ONS Chemotherapy and Biotherapy Provider Card. This card validates the participant has the theoretical foundation needed to administer cytotoxic and biotherapeutic agents. The card is valid for two years. Course Objectives Upon completion of the course, the participant will be able to: • Identify various therapeutic modalities used to treat cancer with emphasis on chemotherapy and biotherapy. • Describe the investigational process all drugs undergo to gain approval for use. • Review ethical and legal issues related to cancer therapy. • Identify factors affecting response to cancer therapy. • Identify selected commonly used agents, their mechanisms of action, and any unique administration issues.
  2. 2. • Discuss safety precautions necessary when handling cytotoxic agents. • Review chemotherapy dose calculations and practice examples. • Identify nursing procedures and interventions for administering cytotoxic and biologic agents. • Discuss two immediate complications of cancer therapy, extravasation and hypersensitivity, and the nursing measures required to prevent and/or reduce these complications. • Identify selected systematic side effects of cytotoxic and biotherapeutic agents and the nursing interventions required to manage these side effects. • Review specific patient and family education that may prevent and/or reduce the impact of systemic side effects. Program Schedule Introduction Definition of cancer Treatment modalities Drug development process/clinical trial process Ethical and legal issues Goals of Cancer therapy and measuring response Principles of chemotherapy Principles of biotherapy Principles of Targeted Therapy
  3. 3. Safe practice considerations Administration Dose determination Pre-treatment care Routes of administration Immediate complications of cytotoxic therapy Care of the patient receiving chemotherapy/biotherapy Side effects of cancer therapy Myelosuppression GI and mucosal side effects Cutaneous Toxicity Alopecia Cardiovascular toxicity Pulmonary toxicity Hemorrhagic cystitis Hepatotoxicity Nephrotoxicity Neurotoxicity Cognitive changes Ocular Toxicity Pancreatitis
  4. 4. Fatigue Alterations in Sexual and Reproductive function Secondary Malignancies Survivorship Care Plan Case Studies Target Audience Participants must be licensed registered nurses who have been employed as such for a minimum of six months. This course content is appropriate for nurses who are new to chemotherapy administration, as well as for those who want a comprehensive review. Continuing Nursing Education Credit: ONS will award 13.5 contact hours to nurses who attend this program in its entirety. ONS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. ONS is approved as a provider of continuing nursing education by the California State Board of Registered Nursing, Provider No. 2850. Course Faculty The course faculty includes experience oncology nurses who have successfully completed the Oncology Nursing Society’s Cancer Chemotherapy and Biotherapy Trainer course. By limiting course instructors to nurses who have been approved as trainers, ONS ensures that every participant will receive consistent, updated information. Faculty members include: Rachel Behrendt, MSN, APN-C, AOCNS Deena Centofanti, MS, RN, AOCN
  5. 5. Stephanie Grospe, MSN, RN, OCN Melanie Harrow, BSN, RN, OCN Kathy Leifeste, RN, MSN, AOCN Leah Scaramuzzo, MSN, RNC, AOCN Carla Schaefer, BSN, RN, OCN Susan Schwartz, MSN, RN Molly Sullivan, BSN, RN, OCN Lois Talty, BSN, RN, OCN Fees Two-day didactic course- $300. This includes meals, all course materials, copy of the Chemotherapy and Biotherapy Guidelines and Recommendation for Practice, 3rd Ed., and Continuing Nursing Education Credits Location and Time 7:30a.m -5:00 p.m. The didactic course will be presented in the Auditorium on the first floor of The Cancer Institute of New Jersey, 195 Little Albany, New Brunswick, New Jersey. Registration Form For more information about these courses, please contact Nursing Education at 732-235-8784 or via e-mail at nursinged-cinj@umdnj.edu.

×